Sera Prognostics SERA
NASDAQ SERA
$2.14 +0.04 (+1.90%)
At close: Aug 21, 2026 · 4:00 PM EDT

Sera Prognostics (SERA) EBIT Margin Growth (1y) (2021 - 2026)

Sera Prognostics (SERA) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -497.00
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 670.00
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 301.00
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 546.00
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 264.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 595.00
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 89.00
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -247.00
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 146.00
10 Sera Prognostics 108.53 Mn 108.53 Mn -20,000.00 2.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.15 Mn
Mar 31, 2026 -4.25 Mn
Dec 31, 2025 -5.03 Mn
Sep 30, 2025 -2.56 Mn
Jun 30, 2025 -1.63 Mn
Dec 31, 2024 -1.77 Mn
Sep 30, 2024 -1.11 Mn
Jun 30, 2024 -2.92 Mn
Dec 31, 2023 -555,280.00
Sep 30, 2023 -662,594.00
Jun 30, 2023 574,190.00
Mar 31, 2023 2.10 Mn
Dec 31, 2022 3.22 Mn
Sep 30, 2022 2.82 Mn
Jun 30, 2022 2.18 Mn
Mar 31, 2022 1.40 Mn
Dec 31, 2021 3.10 Mn
Sep 30, 2021 5.18 Mn
Jun 30, 2021 3.44 Mn